Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Diversity Matters: A Revised Guide to Myelination.
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Balo Concentric Sclerosis in Children: A Case Series.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
The association between multiple sclerosis and fracture risk.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Higher education moderates the effect of t2 lesion load and third ventricle width on cognition in multiple sclerosis.
In vitro myelin formation using embryonic stem cells.
A study of psychological well-being in people with multiple sclerosis and their primary caregivers.
Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice.
Percutaneous angioplasty of internal jugular and azygous veins in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis: early and mid-term results.
Validity of korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire.
The development of primary central nervous system B-cell lymphoma in multiple sclerosis.
Accuracy and Reproducibility of a Quantitative Magnetic Resonance Imaging Method for Concurrent Measurements of Tissue Relaxation Times and Proton Density.
Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry.
A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs.
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation.
Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.
Coexistence of Multiple Sclerosis and Ankylosing Spondylitis: Report of Two Cases.
Pages
« first
‹ previous
…
565
566
567
568
569
570
571
572
573
…
next ›
last »